How does odevixibat stop the itching and bile acid buildup?
Odevixibat blocks the ileal bile acid transporter protein in your small intestine, preventing bile acids from being recycled back into your bloodstream. This causes bile acids to exit your body instead of accumulating, reducing serum bile acids by 40–60% and cutting severe itching in 60–70% of patients within 4–8 weeks [1][2].
In Phase 3 trials, odevixibat reduced serum bile acids from >100 µmol/L to 20–50 µmol/L in PFIC and Alagille syndrome patients. Itching scores improved by ≥50% in 60–70% of participants. The effect appears within 2–4 weeks and plateaus by week 8 [1][2].
Your liver makes bile acids to digest fat. Normally, your small intestine recycles 95% of them back into your bloodstream. In PFIC and Alagille syndrome, this recycling goes haywire, and bile acids pile up, triggering severe itching and liver damage. Odevixibat stops the recycling pump, so bile acids leave your body instead [3][4].
The trade-off is increased diarrhea (30–40% of patients) and fat-soluble vitamin deficiency (vitamins A, D, E, K). You'll need vitamin monitoring every 6 months and may need supplements costing $15–40/month. Most patients find the itching relief worth the diarrhea and vitamin management [3][8].
Ask your hepatologist: 'What is my current serum bile acid level, and is it above 100 µmol/L?' If yes, odevixibat may be right for you. Request baseline vitamin A, D, E, and K levels before starting, and schedule a recheck at 8 weeks to confirm the bile acid drop [1].